外周血管畸形栓塞硬化治疗的辐射暴露
该研究基于单中心前瞻性数据库,回顾分析2013—2018年237例患者共419次外周血管畸形栓塞硬化治疗(EST)的辐射暴露。中位单次DAP为1.26 Gycm2、累积1.91 Gycm2;AVM患者的DAP和透视时间均显著高于静脉及淋巴管畸形(P<.01)。
要点
- EST总体辐射暴露低于已报道的动脉及深静脉介入,但个别患者剂量较高
- AVM患者单次及累积EST的DAP与透视时间均显著高于静脉及淋巴管畸形
- 不同解剖部位的DAP存在显著差异,透视时间无显著差异
核心结论
- 外周血管畸形EST的患者辐射暴露以DAP和透视时间衡量,总体低于已报道的动脉和深静脉介入,但部分患者接受相对较高的辐射剂量。
- 仍需进一步研究这些患者辐射暴露的危险因素、长期不良反应及降低照射的策略。
研究设计与样本
- 单中心、前瞻性收集数据库的回顾性分析,研究期为2013年1月1日至2018年1月8日。
- 共237例患者(中位年龄30岁,范围1-73岁)接受419次EST,其中AVM 61例(25.7%)行140次EST,静脉及淋巴管畸形176例(74.3%)行279次EST。
- 辐射暴露以剂量面积乘积(DAP)和透视时间衡量,采用Mann-Whitney U检验和Kruskal-Wallis检验比较亚组,P<.05为有统计学意义。
主要发现
- 单次EST中位DAP为1.26 Gycm2(范围0.00-698.36 Gycm2),累积中位DAP为1.91 Gycm2(范围0.00-1300.24 Gycm2)。
- 单次EST中位透视时间为19秒(范围1-3846秒),累积中位透视时间为30秒(范围1-5843秒)。
- AVM患者中位手术次数为2次(范围1-13),静脉及淋巴管畸形为1次(范围1-6)。
- AVM与静脉及淋巴管畸形相比,单次及累积EST的DAP和透视时间均显著更高(两项均P<.01,Mann-Whitney U检验)。
- 比较血管畸形解剖区域时,DAP存在显著差异,透视时间无显著差异。
临床怎么用
- 可参考本研究DAP与透视时间水平评估外周血管畸形EST的辐射剂量,并对AVM及高暴露患者加强剂量监测与防护。
局限性
- 为单中心回顾性分析,仅反映该中心5年期间经验,辐射暴露的危险因素与长期不良反应未在本研究中阐明。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Embolo-sclerotherapy (EST) is the mainstay therapy for peripheral vascular malformations that involves the exposure of patients to ionizing radiation. We analyzed the radiation exposure to patients from EST of peripheral vascular malformations during a 5-year period in a single specialist center. METHODS: All patients who had undergone EST at a single specialist center for peripheral vascular malformations from January 1, 2013 to January 8, 2018 were identified from a prospectively collected database. Data collection included basic demographics, procedure date, anatomic site, type of vascular malformations, and procedural details. Radiation exposure, measured as the dose-area product (DAP) and fluoroscopy time, of all patients who had undergone EST during the study period were retrospectively reviewed. Statistical analysis was performed using the Mann-Whitney U and Kruskal-Wallis tests for comparison between subgroups. P < .05 was considered statistically significant. RESULTS: A total of 237 patients (median age, 30 years; range, 1-73 years) had undergone 419 EST sessions during the study period. Of the 237 patients, 61 (25.7%) had had arteriovenous malformations (AVMs) and had undergone 140 EST sessions (33.4%) and 176 (74.3%) had had venous and lymphatic malformations and had undergone 279 EST sessions (66.6%). Patients with AVMs had undergone a median of 2 procedures (range, 1-13) compared with a median of 1 (range, 1-6) for venous and lymphatic malformations within the study period. The median DAP for the single and cumulative EST for peripheral vascular malformations was 1.26 Gycm2 (range, 0.00-698.36 Gycm2) and 1.91 Gycm2 (range, 0.00-1300.24 Gycm2), respectively. The median fluoroscopy time for single and cumulative EST was 19 seconds (range, 1-3846 seconds) and 30 seconds (range, 1-5843 seconds), respectively. Significantly greater patient radiation exposure, in DAP and fluoroscopy time, was measured for single and cumulative EST for AVMs compared with venous and lymphatic malformations (P < .01 for both; Mann-Whitney U test). A significant difference in DAP but not fluoroscopy time was found when the anatomic areas of vascular malformations were compared. CONCLUSIONS: Patient radiation exposure for EST for peripheral vascular malformations, measured in DAP and fluoroscopy time, appeared to be generally less than that reported for endovascular arterial and deep venous interventions. However, some patients with peripheral vascular malformations received relatively high radiation doses. Further studies to investigate the risk factors and long-term side effects of radiation exposure in these patients and strategies to reduce these are required.
引用
- Giet L, Evans N, Papadopoulou A, et al. Patient radiation exposure from embolo-sclerotherapy of peripheral vascular malformations. J Vasc Surg. 2020. PMID: 33075453. doi:10.1016/j.jvs.2020.08.152
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。